Category Archives: Health

Health and Wellness News and Tips

Pandemic good news…


Date: September 21, 2022

01) LINK

“CDC variant report

Some increase in BA.4.6 and BA.2.75


Progressive US increase, starting to slowly displace BA.5

US of America (9,526)

Canada (1,007)

Denmark (500)

France (400)

Australia (288)

Germany (248)

Chile (242)

Dominican Republic (173), Peru (149), Luxembourg (123), Belgium (102), Israel (101), Italy (94), Ireland (93), Sweden (92), Spain (85), Netherlands (84), Brazil (76), Argentina (68), Japan (67), New Zealand (60), Switzerland (54), Puerto Rico (53), South Africa (53), Ecuador (49), Mexico (35), Colombia (34), Trinidad and Tobago (30), Czech Republic (27), Costa Rica (23), Jamaica (21), Portugal (20), South Korea (19), Austria (17), Botswana (17), Indonesia (13), Sint Maarten (12), Senegal (11)


Some US increase

Growth rate is currently 61% per week relative to co-circulating lineages

Current US nowcast

BA.5 84.8% (UK, 87.2%)

BA.4.6 10.3% (UK, 3.3)

BA.4 1.8%

BF.7 1.7%

BA.2.75 1.3% (UK, 1.6%)

BA.2 0% (UK, 0.5%)

BA.1s 0%

Delta 0%

Others 0% (UK, 2.4%)

XE 0%

UK, technical briefing 45

(September 2022)

Contains early data and analysis on emerging variants

Findings have a high level of uncertainty

Data cut-off of 5 September 2022


BA.5 is the predominant circulating variant in the United Kingdom

Newly designated variant – V-22SEP-01 (BA.4.6)

Omicron sub-lineage BA.4.6

An apparent small growth advantage relative to BA.5.

BA.4.6 represented 3.31% of UK samples

Preliminary neutralisation data from BA.4.6

Expect some immune escape from BA.4 or BA.5 antibodies

There is NO increased risk of hospital admission after BA.4 or BA.5 infection compared to BA.2 infection.

Expect some immune escape triple dosed recipients of the Pfizer BNT162b2 vaccine.

V-22JUL-01 (BA.2.75)

As of 6 September 2022

BA.2.75 in the UK, 1.6%

Does seem to have growth advantage over co-circulating lineages of,

61% per week

Two sub-lineages of BA.2.75 (BA.2.75.1 and BA.2.75.2) are currently being assessed

BA.4/BA.5 Severity

A case-control study

Risk of being admitted to hospital as an inpatient

Among people presenting to emergency care within 14 days of positive test.

Comparison, risk of admission with BA.4 or BA.5 versus BA.2

Between 16 March 2022 and 23 August 2022

BA.4 n = 2,530

BA.5 n = 12,026

BA.2 n = 17,022

Adjusted for age, sex, vaccination status, week of test, 2 days of extreme heat

There was no difference in the risk of admission between people infected with BA.4 compared to BA.2

There was no difference in the risk of admission between people infected with BA.5 compared to BA.2″


The World Within Us: Microbes That Help and Harm…


Date: August 24, 2022

01) LINK

“(October 27, 2009) Julie Theriot, Associate Professor of Biochemistry and of Microbiology and Immunology at Stanford, discusses the different types of microorganisms present in the human body and their functions, the distinction between disease-causing and benign or helpful microorganisms, and the interactions between human cells and both harmful and helpful microorganisms.

Stanford Mini Med School is a series arranged and directed by Stanford’s School of Medicine, and presented by the Stanford Continuing Studies program.”

Over twelve years old…so, take that into account…There may have been some advances in understanding since.


Trump Lowered Insulin Prices – Biden Just REVERSED IT!…

Date: August 17, 2022

01) LINK

“Near the end of his administration, Donald Trump issued an executive order that would provide government assistance to reduce the cost of insulin for low-income diabetics. Before the order could be implemented, Joe Biden took office and his administration delayed and eventually reversed the decision. And now, with the Inflation Reduction Act reducing the cost of insulin for diabetics on Medicare, the already sky-high insulin price paid by anyone NOT on Medicare will likely go up.

Jimmy and America’s comedian Kurt Metzger discuss Big Pharma’s grip on pharmaceutical pricing and why Americans pay so much more for prescription drugs than anyone else in the world.”